31 related articles for article (PubMed ID: 23235385)
1. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.
Grippo PJ; Sandgren EP
Am J Pathol; 2000 Sep; 157(3):805-13. PubMed ID: 10980120
[TBL] [Abstract][Full Text] [Related]
2. GW4064 inhibits migration and invasion through cathepsin B and MMP2 downregulation in human bladder cancer.
Kao CC; Lai CR; Lin YH; Chen TM; Tsai YL; Tsai WC; Ong TY; Wang HH; Wu ST; Chen Y
Chem Biol Interact; 2024 Feb; 389():110869. PubMed ID: 38216027
[TBL] [Abstract][Full Text] [Related]
3. Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer.
Li Y; Xu X; Song L; Hou Y; Li Z; Tsang S; Li F; Im KM; Wu K; Wu H; Ye X; Li G; Wang L; Zhang B; Liang J; Xie W; Wu R; Jiang H; Liu X; Yu C; Zheng H; Jian M; Nie L; Wan L; Shi M; Sun X; Tang A; Guo G; Gui Y; Cai Z; Li J; Wang W; Lu Z; Zhang X; Bolund L; Kristiansen K; Wang J; Yang H; Dean M; Wang J
Gigascience; 2012 Aug; 1(1):12. PubMed ID: 23587365
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 mediated Y-chromosome elimination affects human cells transcriptome.
Celli L; Gasparini P; Biino G; Zannini L; Cardano M
Cell Biosci; 2024 Jan; 14(1):15. PubMed ID: 38291538
[TBL] [Abstract][Full Text] [Related]
5. Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1.
Sathe G; George IA; Deb B; Jain AP; Patel K; Nayak B; Karmakar S; Seth A; Pandey A; Kumar P
Oncotarget; 2020 Aug; 11(34):3244-3255. PubMed ID: 32922663
[TBL] [Abstract][Full Text] [Related]
6. Effect of T-cadherin on the AKT/mTOR signaling pathway, gastric cancer cell cycle, migration and invasion, and its association with patient survival rate.
Lin J; Chen Z; Huang Z; Chen F; Ye Z; Lin S; Wang W
Exp Ther Med; 2019 May; 17(5):3607-3613. PubMed ID: 30988743
[TBL] [Abstract][Full Text] [Related]
7. CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells.
Wang Y; Zhang L; Yang J; Li B; Wang J
Oncol Lett; 2018 Nov; 16(5):5715-5722. PubMed ID: 30344726
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in
Li Y; Li C; Ma Q; Zhang Y; Yao Y; Liu S; Zhang X; Hong C; Tan F; Shi L; Yao Y
Oncotarget; 2018 Jan; 9(1):881-891. PubMed ID: 29416663
[TBL] [Abstract][Full Text] [Related]
9. Protective role of Cadherin 13 in interneuron development.
Killen AC; Barber M; Paulin JJW; Ranscht B; Parnavelas JG; Andrews WD
Brain Struct Funct; 2017 Nov; 222(8):3567-3585. PubMed ID: 28386779
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
Lin YL; Gui SL; Ma JG
Oncol Lett; 2015 Aug; 10(2):647-652. PubMed ID: 26622548
[TBL] [Abstract][Full Text] [Related]
11. Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective Cells.
Cremaschi P; Oliverio M; Leva V; Bione S; Carriero R; Mazzucco G; Palamidessi A; Scita G; Biamonti G; Montecucco A
PLoS One; 2015; 10(7):e0130561. PubMed ID: 26151554
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer.
Lin YL; Xie PG; Ma JG
Med Sci Monit; 2014 Sep; 20():1572-7. PubMed ID: 25196672
[TBL] [Abstract][Full Text] [Related]
13. An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.
Iglesias Gómez JC; Mosquera Orgueira A
Front Oncol; 2014; 4():147. PubMed ID: 25003081
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of CDH13 expression promotes invasiveness of bladder transitional cell carcinoma.
Lin YL; He ZK; Li ZG; Guan TY
Urol Int; 2013; 90(2):225-32. PubMed ID: 23235385
[TBL] [Abstract][Full Text] [Related]
15. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ.
Bindels EM; Vermey M; van den Beemd R; Dinjens WN; Van Der Kwast TH
Cancer Res; 2000 Jan; 60(1):177-83. PubMed ID: 10646871
[TBL] [Abstract][Full Text] [Related]
17. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of apoptotic activity in muscle-invasive bladder cancer.
Ristić A; Velicković LJ; Stokanović D
Vojnosanit Pregl; 2011 Jun; 68(6):511-4. PubMed ID: 21818919
[No Abstract] [Full Text] [Related]
19. [Identification of RalGAPs and their downregulation in invasive bladder cancer].
Shirakawa R; Horiuchi H
Seikagaku; 2014 Oct; 86(5):671-5. PubMed ID: 25509336
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
